Meetings Events & Conference Coordinators 17th Annual California Cancer Consortium Conference 2021
Format:26 videos, size: 7.03 GB
Course Audience: oncologist
Overview:
This educational meeting was developed in cooperation with the academic faculty and scientists belonging to the California Cancer Consortium to provide an annual in-depth exposure and review of new advances in cancer drug development, biology, biomarkers, diagnosis, and therapy. The agenda and format are specifically designed to address knowledge gaps identified from prior course participant evaluations and unsolicited comments from practicing oncologists (from private practice, academia) as well as scientists involved in cancer clinical trials. This area of knowledge will be best addressed by an in-depth conference on systemic therapy of malignancies (both solid and hematologic), with ample time provided for interaction by attendees with expert faculty. It is expected that this educational activity will enhance the clinical competence of clinicians and the healthcare team in managing the care of the cancer patient, and subsequently, improve patient outcomes.
This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together the interprofessional team that includes, respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances. Topics focus on the major cancers and drug development areas, including signal transduction/CDK inhibition, angiogenesis inhibition, PI3K/mTOR inhibition, antibody-drug conjugates, and immunotherapy, among others. This annual conference also includes interactive roundtable discussion forums with participation of cancer care experts from the California Cancer Consortium, and features renowned professionals from academia, patient advocacy, government, payer, industry, and business realms of cancer care.
Aug 20 Cancer Immunotherapy Current and Next Generation Biomarkers (Video MP4 Format)
Aug 20 Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy (Video MP4 Format)Aug 20 How I treat Stage III NSCLC (Video MP4 Format)Aug 20 Management of Immune Related Adverse Events (Video MP4 Format)Aug 20 PK PD Considerations in Early Phase Clinical Trials (Video MP4 Format)Aug 20 Progress in CAR-T Cell Therapies (Video MP4 Format)Aug 21 2021 Update Small Cell Lung Cancer and Mesothelioma (Video MP4 Format)Aug 21 Advanced Urothelial Cancer (Video MP4 Format)Aug 21 Advances in Pancreatic Cancer (Video MP4 Format)Aug 21 AML Current Status and Future Directions (Video MP4 Format)Aug 21 At Long Last, Progress in Gastro-Esophageal Cancer (Video MP4 Format)Aug 21 Castration resistant prostate cancer What is the optimal approach (Video MP4 Format)Aug 21 Head and neck cancer updates, October 2021 California Cancer Consortium (Video MP4 Format)Aug 21 Immunotherapy for Non-Small Cell Lung Cancer Integration of Predictive Biomarkers (Video MP4 Format)Aug 21 Low Risk MDS Management Approaches (Video MP4 Format)Aug 21 Novel and Emerging Treatment of Relapsed Refractor Diffuse Large B Cell Lymphoma (Video MP4 Format)Aug 21 Precision Therapy for Lung Adenocarcinoma in 2021 (Video MP4 Format)Aug 21 Renal Cell Cancer Emerging Standards of Care and Future Directions (Video MP4 Format)Aug 21 State of the Art Hormone Sensitive Prostate Cancer (Video MP4 Format)Aug 21 Updates in Targeted Therapies (Video MP4 Format)Aug 21 Updates in Treatment of Early Stage (Video MP4 Format)Aug 22 Advances in Metastatic Breast Cancer (Video MP4 Format)Aug 22 Early Breast Cancer (Neo) Adjuvant Update (Video MP4 Format)Aug 22 HER2-Positive Metastatic Breast Cancer (Video MP4 Format)Aug 22 NCI CTEP IND program What we are and where we are going (Video MP4 Format)Aug 22 Telemedicine in Cancer in the Age of COVID (Video MP4 Format)